La comunidad latina es una de las afectadas por la obesidad, enfermedad que afecta tanto física como emocionalmente e incrementa el riesgo de depresión, diabetes, hipertensión, enfermedades del corazón, complicaciones de COVID 19 y cáncer.

¡Estamos aceptando a las primeras 100 personas que califican! Clic en el siguiente enlace para registrarse o contactenos al (909) 300-5066.

Regístrese

The Latino community is one of the communities most affected with obesity, a disease which affects both physical health and increases the risk of depression, diabetes, hypertension, heart health, COVID-19 complications and cancer. 

We are accepting the first 100 persons who identify as Latino and have obesity (30 to 50 lbs more than their ideal weight) and do not have diabetes.

Click on the link below to register or contact us at (909) 300-5066.

Register Now

Latino crossover Semaglutide study (LCSS)

PREGUNTAS FRECUENTES/ Frequently Asked Questions

¿Quien califica?/ Who is eligible for the study?

  • Es Latino/Hispanico / You consider yourself Latino or Hispanic
  • 30 a 50 lbs de sobrepeso / overweight by 30 to 50 lbs 
  • No tiene diabetes / You do not have diabetes

 

¿Que necesita hacer?/ What do you need to do?

  • Llegar a la orientación / Show up on Orientation Day
  • Decidir si el programa es para usted / Decide then if this program is for you.
  • Completar 12 meses del programa semanal / Attend monthly appointments in Loma Linda, CA
  • Completar 8 semanas de clases de Full Plate Living (para mejorar su alimentacion y si nivel de estrés).  

If you have any further questions or for more information, please contact the Vida Plena team at (909) 884-3735.

¿Beneficios?/ What are the benefits of this study?

  • Free access to an application called “Virtual Health Partners – Virtual Wellness and Weight loss”
  • Weekly injections to reduce your appetite (approved by the  FDA)
  • $500 in gift cards to be given as follows:
  • $100 after completing 2 months
  • $100 after completing 6 months
  • $150 after completing 8 months
  • $150 after completing 12 months

 

  • Acceso gratis a una aplicación llamada Virtual Health Partners – Virtual Wellness and Weight loss”
  • Inyecciones semanales para reducir su apetito / Weekly injections to reduce your appetite (approved by the FDA)
  • $500 en tarjetas de regalo/ in gift cards:
  • $100 - después de 2 meses / after completing 2 months
  • $100 - al completar 6 meses / after completing 6 months
  • $150 - después de 8 meses / after completing 8 months
  • $150 - a los 12 meses/ when completing 12 months

How long will this study last?/ ¿Cuánto tiempo dura este estudio?

12 months / 12 meses

Research Team

Dr. Warren Peters

Dr. Warren Peters

Principal Investigator

Warren Peters MD MPH FOMA, is an associate professor and director of obesity research at the School of Public Health.  He is the PI for this Investigator Supported Study (ISS), funded by Novo Nordisk, The Latino Cross Over Semaglutide Study (LCSS).  It has been given the popular name, Reto Vida Plena and will assess the effect of “pharmaceutically supported” lifestyle changes leading to health and maintenance of a health weight. He is and has been the PI on other obesity, insulin resistance, and lifestyle studies.  

Dr. Johnny D. Figueroa

Dr. Johnny D. Figueroa

Co-principal Investigator

I am an Associate Professor of Neuroscience in the Department of Basic Sciences and the Center for Health Disparities and Molecular Medicine at the Loma Linda University School of Medicine. I conduct translational research on identifying neurobiological pathways connecting early-life stress to obesity with a cross-cutting theme of reducing health disparities. In addition to my scholarly contributions, I serve in leadership roles in multiple national and regional organizations and professional societies.

Dr. Maud Joachim-Célestin

Dr. Maud Joachim-Célestin

Community Medical Liaison

Dr. Maud Joachim-Célestin is an assistant research professor at Loma Linda University School of Behavioral Health and an adjunct faculty in the department of Preventive Medicine at Loma Linda University School of Medicine. She has served as principal investigator and co-investigator for community-health worker led interventions among underserved populations struggling with chronic diseases. Besides overseeing translational research in chronic disease prevention (primarily obesity and diabetes) she teaches Medical Terminology and portions of the clinical community health worker training at San Manuel Gateway College. In the Latino Crossover Semaglutide study she serves as medical liaison, overseeing and coordinating the community health worker team-patient activities.
 

Amandeep Kaur

Amandeep Kaur

Research Manager

Amandeep Kaur is a Research Manager at the Loma Linda University School of Public Health. She has experience with conducting research trials for the past 7 years. Her main expertise is in the field of subject recruitment, coordinating research trials and being a liaison between funding agencies as well as other research partners such as the School of Medicine, Basic science, Behavioral Health etc. She is also actively involved in getting IRB approvals and oversees personnel working in research.